Recent studies in literature, have raised some doubts on the routine use of urodynamic testing. Many physicians and articles recommend a selective use of this tool, considering carefully risks and benefits. These recommendations are intended to guide clinicians in the right selection of the male and neurological patients to submit to a urodynamic evaluation. This is the second part of a previous article regarding the urodynamic recommendations in the female population. We reviewed the literature, regarding the use of UDS in male and neurological population with lower urinary tract symptoms (LUTS). Specifically, we analyzed and compared the guidelines and recommendations of the most important urology and urogynecology international scientific societies. These publications were used to create the evidence basis for characterizing the recommendations to perform urodynamic testing. A panel of 10 experts was composed and Delphi process was followed to obtain the panelist consensus. The final recommendations were approved by the unanimous consensus of the panel and compared with the best practice recommendations available in the literature. The recommendations are provided for diagnosis and management of common LUTS in male and neurological population. This review provides a summary of the most effective utilization of urodynamic studies for the global evaluation of patients with LUTS, and how to use them when really needed, avoiding unnecessary costs and patient inconveniences.

When should we use urodynamic testing? Recommendations of the Italian Society of Urodynamics (SIUD). Part 2. Male and neurogical population / Braga, A.; Serati, M.; Illiano, E.; Manassero, F.; Milanesi, M.; Natale, F.; Torella, M.; Pistolesi, D.; De Nunzio, C.; Soligo, M.; Agro, E. F.. - In: MINERVA UROLOGICA E NEFROLOGICA. - ISSN 0393-2249. - 72:2(2020), pp. 187-199. [10.23736/S0393-2249.19.03447-7]

When should we use urodynamic testing? Recommendations of the Italian Society of Urodynamics (SIUD). Part 2. Male and neurogical population

Illiano E.;Milanesi M.;De Nunzio C.;Soligo M.;
2020

Abstract

Recent studies in literature, have raised some doubts on the routine use of urodynamic testing. Many physicians and articles recommend a selective use of this tool, considering carefully risks and benefits. These recommendations are intended to guide clinicians in the right selection of the male and neurological patients to submit to a urodynamic evaluation. This is the second part of a previous article regarding the urodynamic recommendations in the female population. We reviewed the literature, regarding the use of UDS in male and neurological population with lower urinary tract symptoms (LUTS). Specifically, we analyzed and compared the guidelines and recommendations of the most important urology and urogynecology international scientific societies. These publications were used to create the evidence basis for characterizing the recommendations to perform urodynamic testing. A panel of 10 experts was composed and Delphi process was followed to obtain the panelist consensus. The final recommendations were approved by the unanimous consensus of the panel and compared with the best practice recommendations available in the literature. The recommendations are provided for diagnosis and management of common LUTS in male and neurological population. This review provides a summary of the most effective utilization of urodynamic studies for the global evaluation of patients with LUTS, and how to use them when really needed, avoiding unnecessary costs and patient inconveniences.
2020
guidelines as topic; lower urinary tract symptoms; urinary bladder, neurogenic; urinary incontinence; urodynamics
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
When should we use urodynamic testing? Recommendations of the Italian Society of Urodynamics (SIUD). Part 2. Male and neurogical population / Braga, A.; Serati, M.; Illiano, E.; Manassero, F.; Milanesi, M.; Natale, F.; Torella, M.; Pistolesi, D.; De Nunzio, C.; Soligo, M.; Agro, E. F.. - In: MINERVA UROLOGICA E NEFROLOGICA. - ISSN 0393-2249. - 72:2(2020), pp. 187-199. [10.23736/S0393-2249.19.03447-7]
File allegati a questo prodotto
File Dimensione Formato  
Braga_When-should_2020.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 404.12 kB
Formato Adobe PDF
404.12 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1456541
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 6
social impact